Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$860M |
| 2 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$277M |
| 3 |
JD.com
JD
|
+$232M |
| 4 |
Fortive
FTV
|
+$225M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$408M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$358M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.1% |
| 2 | Financials | 4.96% |
| 3 | Consumer Discretionary | 3.91% |
| 4 | Healthcare | 3.67% |
| 5 | Industrials | 2.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Rhythm Pharmaceuticals
RYTM
$7.62B
| $801K | ﹤0.01% |
27,434
+25,678
| +1,462% | +$811K |
|
3702
Tenaris
TS
$28.8B
| $800K | ﹤0.01% |
23,866
-80,221
| -77% | -$2.78M |
|
3703
PUT
Barclays
BCS
$95.9B
| $799K | ﹤0.01% |
93,407
-12,238
| -12% | -$114K |
|
3704
Revvity
RVTY
$12.8B
| $797K | ﹤0.01% |
8,187
+1,429
| +21% | +$123K |
|
3705
iShares Core S&P US Value ETF
IUSV
$27.6B
| $796K | ﹤0.01% |
14,121
+38
| +0.3% | +$2.12K |
|
|
TMX
3706
DELISTED
Terminix Global Holdings, Inc.
TMX
| $796K | ﹤0.01% |
19,131
-13,266
| -41% | -$531K |
|
|
MLNX
3707
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $796K | ﹤0.01% |
10,847
-4,879
| -31% | -$393K |
|
3708
PUT
Alerian MLP ETF
AMLP
$12.8B
| $795K | ﹤0.01% |
14,880
-4,340
| -23% | -$234K |
|
|
FARO
3709
DELISTED
Faro Technologies
FARO
| $793K | ﹤0.01% |
12,324
+8,902
| +260% | +$567K |
|
3710
Globus Medical
GMED
$11.1B
| $793K | ﹤0.01% |
13,968
+5,725
| +69% | +$301K |
|
3711
PUT
International Flavors & Fragrances
IFF
$22.5B
| $793K | ﹤0.01% |
+5,700
| New | +$750K |
|
|
EBIX
3712
CALL
DELISTED
Ebix Inc
EBIX
| $792K | ﹤0.01% |
10,000
+5,400
| +117% | +$430K |
|
|
GMZ
3713
DELISTED
Goldman Sachs MLP Income Opportunities Fund
GMZ
| $790K | ﹤0.01% |
12,259
+1,887
| +18% | +$125K |
|
3714
Vanguard Russell 3000 ETF
VTHR
$4.82B
| $789K | ﹤0.01% |
5,900
| – | – |
|
|
KERX
3715
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $789K | ﹤0.01% |
232,013
+214,444
| +1,221% | +$773K |
|
3716
First Trust US Equity Opportunities ETF
FPX
$1.52B
| $786K | ﹤0.01% |
10,581
-934,013
| -99% | -$68.9M |
|
3717
Northwest Natural Holdings
NWN
$2.08B
| $786K | ﹤0.01% |
11,540
+4,643
| +67% | +$303K |
|
3718
Apogee Enterprises
APOG
$897M
| $785K | ﹤0.01% |
19,008
+2,238
| +13% | +$108K |
|
3719
First Trust Technology AlphaDEX Fund
FXL
$2.71B
| $783K | ﹤0.01% |
12,321
+601
| +5% | +$36.4K |
|
3720
Civeo
CVEO
$338M
| $779K | ﹤0.01% |
15,648
+1,178
| +8% | +$55.2K |
|
|
HOME
3721
DELISTED
At Home Group Inc.
HOME
| $779K | ﹤0.01% |
+24,719
| New | +$871K |
|
3722
LPL Financial
LPLA
$28.3B
| $778K | ﹤0.01% |
12,053
-3,924
| -25% | -$260K |
|
|
MDCO
3723
CALL
DELISTED
Medicines Co
MDCO
| $778K | ﹤0.01% |
26,000
-700
| -3% | -$26.4K |
|
|
SPTN
3724
DELISTED
SpartanNash
SPTN
| $777K | ﹤0.01% |
38,706
+11,351
| +41% | +$258K |
|
3725
CTS Corp
CTS
$1.91B
| $776K | ﹤0.01% |
22,636
+16,249
| +254% | +$586K |
|
Similar funds
Citigroup's Q3 2018 Portfolio in Review
As of Q3 2018, Citigroup held 8,061 positions worth $112B, up 3% from $109B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q3 2018 filing shows 420 new, 3,967 increased, 2,814 reduced and 254 closed positions. Its largest new stake was Invesco DWA NASDAQ Momentum ETF: 250,000 shares worth $29.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1B.
By sector, the portfolio is most concentrated in Technology at 5.1% of assets, up from 5% a quarter earlier, followed by Financials and Consumer Discretionary.
- Citigroup's largest Q3 2018 buy was Invesco DWA NASDAQ Momentum ETF: 250,000 shares worth $29.3M.
- Citigroup added most to iShares Russell 2000 ETF in Q3 2018, an estimated $860M increase.
- Citigroup's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1B.
- Citigroup fully exited GGP Inc. in Q3 2018, selling an estimated $163M.
- Citigroup's ten largest holdings make up 22% of its $112B portfolio in Q3 2018.
- Citigroup opened 420 new positions and closed 254 in Q3 2018.
- Citigroup's portfolio value rose 3% quarter-over-quarter to $112B.
Based on Citigroup's 13F filing for Q3 2018, filed 13 Nov 2018.